Costlier Medicare Advantage plans do not always offer better quality
Enrolling in a higher-cost Medicare Advantage plan may not always get seniors better quality health care, according to a new RAND Corporation study.
Aug 29, 2022
0
60
Enrolling in a higher-cost Medicare Advantage plan may not always get seniors better quality health care, according to a new RAND Corporation study.
Aug 29, 2022
0
60
People with kidney failure who do not choose conservative management and have not received a kidney transplant can undergo either hemodialysis, which is typically performed several times a week at a clinic, or at-home peritoneal ...
Aug 18, 2022
0
4
President Joe Biden on Tuesday signed the Inflation Reduction Act into law, making it the most significant health care legislation enacted in more than a decade.
Aug 17, 2022
0
5
Nearly three in 10 Medicare beneficiaries have at least one actinic keratosis diagnosis encounter over five years of follow-up, according to a research letter published online July 27 in JAMA Dermatology.
Aug 16, 2022
0
12
Few insured individuals with hepatitis C virus (HCV) infection receive timely direct-acting antiviral (DAA) treatment, according to research published in the Aug. 9 early-release issue of the U.S. Centers for Disease Control ...
Aug 11, 2022
0
2
The Inflation Reduction Act contains provisions that are expected to lower drug costs for millions of Americans by allowing Medicare to negotiate some drug prices and by limiting the amount of out-of-pocket drug costs for ...
Aug 9, 2022
0
2
Large dialysis chains charge Medicare Advantage plans 27% more for dialysis services compared with what they charge the traditional, fee-for-service Medicare program, according to a new USC analysis.
Aug 2, 2022
0
2
While patients with diabetes on Medicare Advantage plans are more likely to receive preventive treatments, they were less likely to be prescribed newer, more expensive medications and were more likely to have higher blood ...
Jul 7, 2022
0
144
Over 30 million Americans have diabetes, and more than 7 million of them require daily insulin. But the cost of the drug has risen considerably in the last decade. Though U.S. lawmakers are considering policies to address ...
Jul 5, 2022
0
43
Medicare could waste up to $605 million per year on the controversial Alzheimer's drug aducanumab if it is eventually approved for widespread use because it is supplied in vials containing fixed doses that may not be appropriate ...
Jun 27, 2022
1
13